Article By Greg Cima / January 11, 2024
In the immediate wake of the COVID-19 pandemic, there was initial enthusiasm that over-the-counter self-administered tests would see an upshot as some believed the widespread use of antigen-based COVID-19 tests would carry over to tests for other indication.
Outcome Capital Named Top Life Sceneces Investment Banking Firm 2025 by Life Science Review January 2025 Read the full article from Life Science Magazine here: Read More
Read MoreOutcome Capital Life Science Market Pulse January 2025 Click to view our LifeSciences Pulse Newsletter
DownloadWould you like to learn more about working with Outcome Capital or discuss your specific needs?